GO:1990841 promoter-specific chromatin binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990841 promoter-specific chromatin binding is a molecular function describing binding to chromatin associated with gene promoter DNA sequences.
• It enables transcription factors and chromatin-modifying complexes to read promoter identity and regulate gene expression in a promoter-specific manner.
• Key proteins include TATA-binding protein (TBP), SWR1, PRC1.6, GAS41, RFX, MyoD, NRSF, and beta-globin locus regulators.
• Promoter-specific chromatin binding is central to developmental gene control, stress responses, and disease mechanisms such as cancer and neurodegeneration.
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to test causality of promoter-binding factors.
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study promoter-specific chromatin binding at scale.
Description
Promoter-specific chromatin binding (GO:1990841) is a molecular function defined as binding to a section of chromatin that is associated with gene promoter sequences of DNA. This activity allows regulatory proteins to recognize promoter regions within the context of chromatin, rather than naked DNA, and to initiate or repress transcription in a gene-specific manner. Understanding this function is critical because promoter recognition is the first step in assembling the transcriptional machinery and in recruiting chromatin remodelers and modifiers that shape gene expression programs. Researchers study promoter-specific chromatin binding to dissect how cells establish cell-type-specific expression, respond to developmental cues, and misregulate genes in disease. The function is experimentally tractable through genome-wide binding assays, chromatin immunoprecipitation, and CRISPR-based perturbation of the proteins involved.
promoter-specific chromatin binding At A Glance
| GO ID | GO:1990841 |
|---|---|
| GO term | promoter-specific chromatin binding |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding to chromatin associated with gene promoter DNA sequences to regulate transcription |
| Example proteins | TBP, SWR1, PRC1.6, GAS41, RFX, MyoD, NRSF |
| Related processes | Transcription initiation, chromatin remodeling, promoter silencing |
| Disease relevance | Cancer, ferroptosis modulation, neurological disorders |
What Is GO:1990841?
GO:1990841 promoter-specific chromatin binding describes the selective interaction of a protein or protein complex with chromatin that is associated with gene promoter DNA sequences. It is a molecular function that requires both chromatin context and promoter sequence specificity, distinguishing it from general DNA binding or general chromatin binding.
Why Is promoter-specific chromatin binding Important in Cell Biology?
Promoter-specific chromatin binding is important because it determines which genes are active in a given cell and how quickly they respond to signals. Proteins that bind promoter chromatin recruit the basal transcription machinery, remodel nucleosomes, and deposit or remove histone marks, thereby controlling gene expression programs. Dysregulation of these proteins is linked to cancer, developmental disorders, and neurodegeneration.
• Controls transcription initiation by recruiting TBP and RNA polymerase machinery to specific promoters.
• Enables chromatin remodelers such as SWR1 to sense promoters and exchange histones.
• Mediates promoter-specific silencing through complexes like PRC1.6 and HUSH.
• Regulates developmental gene expression, as shown for MyoD in muscle differentiation.
• Modulates stress responses such as ferroptosis via GAS41 anchoring NRF2 on chromatin.
• Influences globin gene switching and erythroid differentiation.
• Provides a mechanism for neuron-specific repression through NRSF-TBP interactions.
• Serves as a target for therapeutic intervention in cancers with aberrant promoter binding.
• Is essential for interpreting the epigenome and for reprogramming cell fate.
• Offers a rich set of targets for CRISPR screens and functional genomics.
Molecular Mechanism of promoter-specific chromatin binding
Promoter recognition in chromatin context
In simple terms: Proteins must find the right gene switch even when DNA is wrapped around histones.
Promoter-specific chromatin binding begins with the recognition of promoter DNA sequences that are packaged into nucleosomes. TATA-binding protein (TBP) associates with human promoters with distinct dynamics, allowing promoter-specific initiation of transcription. The SWR1 chromatin remodeler senses global promoter features and captures nucleosomes to regulate histone exchange. Sequence-specific factors such as RFX can activate methylated promoters by binding their target sequences in chromatin.
Recruitment of chromatin modifiers and remodelers
In simple terms: Once bound, these proteins bring in machines that change how tightly DNA is packed.
After promoter binding, proteins recruit chromatin-modifying complexes. PRC1.6 localizes on chromatin with the HUSH complex to mediate promoter-specific silencing. GAS41 anchors NRF2 on chromatin to modulate ferroptosis-related gene expression. NRSF interacts directly with TBP to reorganize chromatin and repress core promoter activity in neurons.
Coordination with signal transduction
In simple terms: External signals can change which promoters are bound and when.
Promoter-specific chromatin binding is not static; it is coordinated with signaling pathways. MyoD binding and signal transduction cooperate to pattern gene expression during muscle differentiation. Beta-globin gene regulation involves promoter-specific binding events that control globin switching. These examples show that promoter occupancy is dynamically regulated by developmental and environmental cues.
Functional consequences for transcription
In simple terms: The binding event ultimately decides whether a gene is turned on or off.
The outcome of promoter-specific chromatin binding is either activation or repression of transcription. TBP binding promotes preinitiation complex assembly, while PRC1.6-HUSH and NRSF-TBP interactions lead to silencing. SWR1-mediated nucleosome capture alters promoter accessibility and histone variant composition. Thus, the same molecular function can drive opposite transcriptional outcomes depending on the bound factor and context.
Key Genes Involved in GO:1990841 promoter-specific chromatin binding
The following genes and proteins are experimentally implicated in promoter-specific chromatin binding (GO:1990841) based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TBP | Binds TATA-box promoters and initiates transcription | Promoter-specific dynamics studied genome-wide |
| SWR1 | Chromatin remodeler that senses promoters and captures nucleosomes | Global promoter sensing and histone exchange |
| PRC1.6 | Localizes with HUSH complex for promoter-specific silencing | Polycomb-mediated repression |
| GAS41 | Anchors NRF2 on chromatin to modulate ferroptosis | Stress response and cancer |
| RFX | Sequence-specific DNA-binding protein that activates methylated promoters | Epigenetic activation |
| MyoD | Promoter-specific binding patterns gene expression in muscle | Differentiation and signal transduction |
| NRSF | Interacts with TBP for neuron-specific core promoter repression | Neuronal gene silencing |
| HUSH complex | Partners with PRC1.6 for promoter silencing | Chromatin silencing |
| NRF2 | Anchored by GAS41 on chromatin | Ferroptosis and oxidative stress |
| Beta-globin locus regulators | Control beta globin gene promoters | Globin switching and erythroid biology |
| TBP-associated factors | Assist TBP in promoter recognition | Transcription initiation |
| Histone variants | Exchanged by SWR1 at promoters | Chromatin composition |
| HUSH-associated factors | Facilitate promoter-specific localization | Silencing mechanisms |
| MyoD cofactors | Modulate MyoD promoter binding | Muscle gene regulation |
| RFX cofactors | Support activation of methylated promoters | Epigenetic regulation |
| NRSF corepressors | Mediate chromatin reorganization | Neuronal repression |
| GAS41-associated proteins | Stabilize NRF2 chromatin anchoring | Ferroptosis modulation |
How Is promoter-specific chromatin binding Regulated?
Promoter-specific chromatin binding is regulated at multiple levels. TBP association with promoters is dynamic and promoter-specific, suggesting regulation by local chromatin state and transcription factors. SWR1-mediated nucleosome capture is influenced by promoter features and histone modifications. PRC1.6 and HUSH complex localization is controlled by silencing signals. GAS41 anchoring of NRF2 is responsive to ferroptosis-inducing conditions. MyoD binding is coordinated with signal transduction pathways. NRSF-TBP interaction provides a neuron-specific regulatory mechanism.
promoter-specific chromatin binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRC1.6 | Cancer (tumor suppressor silencing) | Knockout in cancer cell lines |
| GAS41 | Cancer, ferroptosis resistance | Point mutation and overexpression models |
| NRSF | Neurodegeneration, epilepsy | Neuron-specific knockout |
| MyoD | Rhabdomyosarcoma, muscle disorders | Knock-in reporter for promoter binding |
| Beta-globin regulators | Beta-thalassemia, sickle cell disease | Knock-in of patient mutations |
Cancer and epigenetic dysregulation
Promoter-specific chromatin binding proteins are frequently dysregulated in cancer. PRC1.6 and HUSH complex-mediated silencing can repress tumor suppressor genes. GAS41 modulates ferroptosis by anchoring NRF2 on chromatin, linking promoter binding to cancer cell survival. MyoD promoter binding is altered in rhabdomyosarcoma and other muscle tumors.
Neurological disorders
NRSF (also known as REST) interacts with TBP to repress neuronal genes; disruption of this promoter-specific repression is implicated in neurodegeneration and epilepsy. RFX-mediated activation of methylated promoters may contribute to neurological gene regulation.
Hematological disorders
Beta-globin gene regulation depends on promoter-specific chromatin binding events; mutations affecting these processes cause beta-thalassemia and sickle cell disease.
From promoter-specific chromatin binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PRC1.6 affect promoter silencing? | CRISPR knockout of PRC1.6 subunits |
| How does GAS41 anchor NRF2 on chromatin? | Point mutation of GAS41 chromatin-binding domain |
| What is the dynamics of TBP at promoters? | Tagged knock-in of TBP for live imaging |
| Does SWR1 promoter sensing require specific residues? | Point mutation knock-in in SWR1 |
| Can RFX activate methylated promoters? | Overexpression of RFX in methylated reporter cells |
| How does NRSF-TBP interaction repress neuronal genes? | Knockout of NRSF in neuronal cells |
How to Study the promoter-specific chromatin binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-seq | Genome-wide promoter occupancy | Mapping TBP, SWR1, PRC1.6 binding |
| RNA-seq | Transcriptional changes | Knockout/overexpression effects |
| CRISPR knockout | Loss-of-function phenotypes | Testing causality of promoter binders |
| Point mutation knock-in | Domain-specific functions | GAS41 chromatin anchoring |
| Reporter assays | Promoter activity | RFX-mediated activation |
| Co-immunoprecipitation | Protein-protein interactions | NRSF-TBP interaction |
| Nucleosome mapping | Chromatin structure at promoters | SWR1-mediated remodeling |
| Globin expression assays | Beta-globin promoter regulation | Hematological disease models |
Genome-wide binding assays
ChIP-seq and related methods measure promoter-specific chromatin binding across the genome. TBP promoter dynamics were mapped genome-wide using such approaches. SWR1 promoter sensing was studied with chromatin immunoprecipitation and nucleosome mapping.
CRISPR perturbation and functional genomics
CRISPR knockout, point mutation, and knock-in models allow causal testing of promoter-binding factors. PRC1.6 and HUSH complex functions were dissected using genetic perturbation. GAS41 chromatin anchoring was tested with point mutants.
Transcriptional readouts
RNA-seq and reporter assays quantify the transcriptional consequences of promoter-specific chromatin binding. MyoD binding patterns were linked to gene expression changes. Beta-globin promoter regulation was studied with globin expression assays.
Biochemical and structural approaches
In vitro binding assays and structural studies reveal how proteins recognize promoter chromatin. RFX binding to methylated promoters was demonstrated biochemically. NRSF-TBP interaction was shown by direct interaction assays.
How CRISPR Can Be Used to Study GO:1990841 promoter-specific chromatin binding
Knockout
CRISPR knockout of genes encoding promoter-specific chromatin binding proteins, such as PRC1.6 subunits or GAS41, allows researchers to test loss-of-function phenotypes in cancer and stress response models.
Point Mutation
Point mutation knock-in can dissect specific domains required for promoter binding, as shown for GAS41 chromatin anchoring and SWR1 promoter sensing.
Knock-in
Tagged knock-in of TBP or other factors enables live-cell imaging and chromatin immunoprecipitation to track promoter-specific binding dynamics.
Overexpression
Overexpression of RFX or MyoD can drive promoter-specific activation or reprogramming, providing gain-of-function models for gene regulation studies.
How EDITGENE Supports promoter-specific chromatin binding Research
Researchers studying promoter-specific chromatin binding-related genes often need to determine whether a candidate gene is causally involved in promoter recognition, chromatin remodeling, or transcriptional regulation. EDITGENE provides validated CRISPR cell models and screening services to accelerate this functional validation.
Contact EDITGENE today to design your custom CRISPR model for promoter-specific chromatin binding research.
Frequently Asked Questions About promoter-specific chromatin binding
What is promoter-specific chromatin binding?
It is a molecular function (GO:1990841) defined as binding to chromatin associated with gene promoter DNA sequences.
What genes are involved in promoter-specific chromatin binding?
Key genes include TBP, SWR1, PRC1.6, GAS41, RFX, MyoD, NRSF, and beta-globin regulators.
How is promoter-specific chromatin binding studied?
Common methods include ChIP-seq, CRISPR knockout, point mutation knock-in, RNA-seq, and reporter assays.
Why is promoter-specific chromatin binding important in cancer?
Dysregulation of proteins like PRC1.6 and GAS41 can silence tumor suppressors or modulate ferroptosis, promoting cancer.
What is the role of TBP in promoter-specific chromatin binding?
TBP binds TATA-box promoters with promoter-specific dynamics to initiate transcription.
How does SWR1 contribute to promoter-specific chromatin binding?
SWR1 senses global promoter features and captures nucleosomes to exchange histones.
What diseases are linked to promoter-specific chromatin binding?
Cancer, neurodegeneration, and beta-thalassemia are linked to dysregulation of these processes.
Can CRISPR be used to study promoter-specific chromatin binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used.
What is the role of NRSF in promoter-specific chromatin binding?
NRSF interacts with TBP to reorganize chromatin and repress neuron-specific core promoters.
How does GAS41 modulate ferroptosis?
GAS41 anchors NRF2 on chromatin to regulate ferroptosis-related gene expression.
Conclusion
Promoter-specific chromatin binding (GO:1990841) is a fundamental molecular function that governs how genes are recognized and regulated within chromatin. The verified literature highlights diverse proteins such as TBP, SWR1, PRC1.6, GAS41, RFX, MyoD, and NRSF that execute this function in development, stress responses, and disease. CRISPR-based models and genome-wide assays are essential to dissect these mechanisms and to translate them into therapeutic strategies.
References
- 1. Rodríguez TC et al.. 2024. PRC1.6 localizes on chromatin with the human silencing hub (HUSH) complex for promoter-specific silencing.. bioRxiv PMID: 39026796
- 2. Hasegawa Y et al.. 2019. Promoter-specific dynamics of TATA-binding protein association with the human genome.. Genome Res 29(12):1939-1950 PMID: 31732535
- 3. Louder RK et al.. 2024. Molecular basis of global promoter sensing and nucleosome capture by the SWR1 chromatin remodeler.. Cell 187(24):6849-6864.e18 PMID: 39357520
- 4. Wang Z et al.. 2024. GAS41 modulates ferroptosis by anchoring NRF2 on chromatin.. Nat Commun 15(1):2531 PMID: 38514704
- 5. Niesen MI et al.. 2005. Activation of a methylated promoter mediated by a sequence-specific DNA-binding protein, RFX.. J Biol Chem 280(47):38914-22 PMID: 16166088
- 6. Bergstrom DA et al.. 2002. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression.. Mol Cell 9(3):587-600 PMID: 11931766
- 7. Mahajan MC et al.. 2007. Control of beta globin genes.. J Cell Biochem 102(4):801-10 PMID: 17910027
- 8. Murai K et al.. 2004. Direct interaction of NRSF with TBP: chromatin reorganization and core promoter repression for neuron-specific gene transcription.. Nucleic Acids Res 32(10):3180-9 PMID: 15197246
